Calcified neurocysticercosis lesions trigger symptomatic inflammation during antiparasitic therapy.
We report a patient with neurocysticercosis who developed numerous cerebral edematous lesions while undergoing cysticidal therapy. These lesions outnumbered viable cystic lesions seen before therapy. Most new lesions were subsequently found to be associated with former calcifications not seen on initial MR imaging. Calcified neurocysticercosis lesions can trigger inflammatory reactions during therapy, and the number and location of calcified neurocysticercosis lesions may influence treatment decisions.
Poeschl
P
P
Department of Neurology, University of Regensburg, Regensburg, Germany.
Janzen
A
A
Schuierer
G
G
Winkler
J
J
Bogdahn
U
U
Steinbrecher
A
A
D000328:Adult; D000923:Anticestodal Agents / Q000009:adverse effects*; D001927:Brain Diseases / Q000150:complications*; D002114:Calcinosis / Q000150:complications*; D004660:Encephalitis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D020019:Neurocysticercosis / Q000150:complications* / Q000188:drug therapy*
D000923:Anticestodal Agents